-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 A5ecRFb3vMk7YNEih1rLq87uQ1/iOA4PVSAkU9uLrh/81APYWliFIZ9HxdmUK0Th
 I+XGgX2l3h+QFOFnN46Zng==

<SEC-DOCUMENT>0001019687-03-002158.txt : 20031023
<SEC-HEADER>0001019687-03-002158.hdr.sgml : 20031023
<ACCEPTANCE-DATETIME>20031023205126
ACCESSION NUMBER:		0001019687-03-002158
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20031014
FILED AS OF DATE:		20031023

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			SWARTZ ERIC S
		CENTRAL INDEX KEY:			0001244108

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-17085
		FILM NUMBER:		03955145

	BUSINESS ADDRESS:	
		STREET 1:		14272 FRANKLIN AVE.
		CITY:			TUSTIN
		STATE:			CA
		ZIP:			92780

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PEREGRINE PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000704562
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				953698422
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0430

	BUSINESS ADDRESS:	
		STREET 1:		14282 FRANKLIN AVE
		CITY:			TUSTIN
		STATE:			CA
		ZIP:			92780
		BUSINESS PHONE:		7145086000

	MAIL ADDRESS:	
		STREET 1:		14282 FRANKLIN AVE
		CITY:			TUSTIN
		STATE:			CA
		ZIP:			92780

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TECHNICLONE CORP/DE/
		DATE OF NAME CHANGE:	19970924

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TECHNICLONE INTERNATIONAL CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>edgar.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>
    <schemaVersion>X0201</schemaVersion>

    <documentType>4</documentType><periodOfReport>2003-10-14</periodOfReport>
    <issuer>
        <issuerCik>0000704562</issuerCik>
        <issuerName>PEREGRINE PHARMACEUTICALS INC</issuerName>
        <issuerTradingSymbol>PPHM</issuerTradingSymbol></issuer><reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001244108</rptOwnerCik>
            <rptOwnerName>SWARTZ ERIC S</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O PEREGRINE PHARMACEUTICALS</rptOwnerStreet1>
            <rptOwnerStreet2>14272 FRANKLIN AVENUE, SUITE 100</rptOwnerStreet2>
            <rptOwnerCity>TUSTIN</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>92780</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
            <reportingOwnerRelationship>
<isDirector>1</isDirector><isOfficer>0</isOfficer><isTenPercentOwner>0</isTenPercentOwner><isOther>0</isOther></reportingOwnerRelationship></reportingOwner><nonDerivativeTable><nonDerivativeHolding><securityTitle><value>Common Stock, $.001 par value</value></securityTitle><postTransactionAmounts><sharesOwnedFollowingTransaction><value>1320765</value></sharesOwnedFollowingTransaction></postTransactionAmounts><ownershipNature><directOrIndirectOwnership><value>D</value></directOrIndirectOwnership><natureOfOwnership><value/></natureOfOwnership></ownershipNature></nonDerivativeHolding><nonDerivativeHolding><securityTitle><value>Common Stock, $.001 par value</value></securityTitle><postTransactionAmounts><sharesOwnedFollowingTransaction><value>236000</value></sharesOwnedFollowingTransaction></postTransactionAmounts><ownershipNature><directOrIndirectOwnership><value>I</value></directOrIndirectOwnership><natureOfOwnership><value>By Swartz Ventures, Inc.</value></natureOfOwnership></ownershipNature></nonDerivativeHol
ding></nonDerivativeTable><derivativeTable><derivativeTransaction><securityTitle><value>Non-Qualified Stock Option (right to buy)</value></securityTitle><conversionOrExercisePrice><value>2.48</value></conversionOrExercisePrice><transactionDate><value>2003-10-14</value></transactionDate><transactionCoding><transactionFormType>4</transactionFormType><transactionCode>A</transactionCode><equitySwapInvolved>0</equitySwapInvolved></transactionCoding><transactionAmounts><transactionShares><value>150000</value></transactionShares><transactionPricePerShare><footnoteId id="F3"/></transactionPricePerShare><transactionAcquiredDisposedCode><value>A</value></transactionAcquiredDisposedCode></transactionAmounts><exerciseDate><footnoteId id="F1"/></exerciseDate><expirationDate><value>2013-10-13</value></expirationDate><underlyingSecurity><underlyingSecurityTitle><value>Common Stock</value></underlyingSecurityTitle><underlyingSecurityShares><value>150000</value></underlyingSecurityShares></underlyingSecurity><postTransaction
Amounts><sharesOwnedFollowingTransaction><value>350000</value></sharesOwnedFollowingTransaction></postTransactionAmounts><ownershipNature><directOrIndirectOwnership><value>D</value></directOrIndirectOwnership><natureOfOwnership><value/></natureOfOwnership></ownershipNature></derivativeTransaction><derivativeTransaction><securityTitle><value>Non-Qualified Stock Option (right to buy)</value></securityTitle><conversionOrExercisePrice><value>2.20</value></conversionOrExercisePrice><transactionDate><value>2003-10-21</value></transactionDate><transactionCoding><transactionFormType>4</transactionFormType><transactionCode>A</transactionCode><equitySwapInvolved>0</equitySwapInvolved></transactionCoding><transactionAmounts><transactionShares><value>350000</value></transactionShares><transactionPricePerShare><footnoteId id="F3"/></transactionPricePerShare><transactionAcquiredDisposedCode><value>A</value></transactionAcquiredDisposedCode></transactionAmounts><exerciseDate><footnoteId id="F2"/></exerciseDate><expirationD
ate><value>2013-10-20</value></expirationDate><underlyingSecurity><underlyingSecurityTitle><value>Common Stock</value></underlyingSecurityTitle><underlyingSecurityShares><value>350000</value></underlyingSecurityShares></underlyingSecurity><postTransactionAmounts><sharesOwnedFollowingTransaction><value>700000</value></sharesOwnedFollowingTransaction></postTransactionAmounts><ownershipNature><directOrIndirectOwnership><value>D</value></directOrIndirectOwnership><natureOfOwnership><value/></natureOfOwnership></ownershipNature></derivativeTransaction><derivativeHolding><securityTitle><value>Warrants to purchase common stock (right to buy)</value></securityTitle><conversionOrExercisePrice><footnoteId id="F3"/></conversionOrExercisePrice><exerciseDate><footnoteId id="F3"/></exerciseDate><expirationDate><footnoteId id="F3"/></expirationDate><underlyingSecurity><underlyingSecurityTitle><value>Common Stock</value></underlyingSecurityTitle><underlyingSecurityShares><footnoteId id="F3"/></underlyingSecurityShares></und
erlyingSecurity><postTransactionAmounts><sharesOwnedFollowingTransaction><value>551828</value></sharesOwnedFollowingTransaction></postTransactionAmounts><ownershipNature><directOrIndirectOwnership><value>D</value></directOrIndirectOwnership><natureOfOwnership><value/></natureOfOwnership></ownershipNature></derivativeHolding><derivativeHolding><securityTitle><value>Warrants to purchase common stock (right to buy)</value></securityTitle><conversionOrExercisePrice><footnoteId id="F3"/></conversionOrExercisePrice><exerciseDate><footnoteId id="F3"/></exerciseDate><expirationDate><footnoteId id="F3"/></expirationDate><underlyingSecurity><underlyingSecurityTitle><value>Common Stock</value></underlyingSecurityTitle><underlyingSecurityShares><footnoteId id="F3"/></underlyingSecurityShares></underlyingSecurity><postTransactionAmounts><sharesOwnedFollowingTransaction><value>419750</value></sharesOwnedFollowingTransaction></postTransactionAmounts><ownershipNature><directOrIndirectOwnership><value>I</value></directOrIndi
rectOwnership><natureOfOwnership><value>By Swartz Ventures, Inc.</value></natureOfOwnership></ownershipNature></derivativeHolding></derivativeTable><footnotes><footnote id="F1">Option represents a replacement option whereby Mr. Swartz voluntarily cancelled an option to purchase up to 150,000 shares of common stock in order to increase the number of options available for grant to other employees of the Company on August 20, 2003.   Of the total shares subject to the option, 97,917 are exercisable on the date of grant to coincide with the vesting terms of the original option grant.  The remaining 52,083 options vest equally over a five month period through March 2004.</footnote><footnote id="F2">One-third of total shares subject to the option are exercisable on the date of grant;
One-third of total shares subject to the option are exercisable on October 14, 2004 and;
One-third of total shares subject to the option are exercisable on October 14, 2005.</footnote><footnote id="F3">Not applicable.</footnote></footnotes><remarks/><ownerSignature><signatureName>By Paul J. Lytle, Power of Attorney for Eric S. Swartz</signatureName><signatureDate>2003-10-23</signatureDate></ownerSignature></ownershipDocument>

</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----